The short answer
Nopal can change meal-related glucose responses, but hypoglycemia from combining Opuntia ficus-indica with glipizide has not been established. Studies of steamed plant material and capsules have different results.
What this answer covers
Opuntia ficus-indica exact species; steamed nopal, dried capsules, fruit and extracts are different exposures.
- Supplement or preparation
- Opuntia ficus-indica
- Medication ingredient
- glipizide
Meal effects depend on preparation
A small study found lower post-meal glucose with steamed nopal in a high-carbohydrate breakfast. Responses differed with the meal composition. This is a food experiment, not a measured glipizide interaction.
Capsule findings were less clear
A separate study found no acute glucose or glucose-tolerance effect from dried nopal capsules. In its diabetic crossover arm, usual glucose-lowering medicine was withdrawn, so it cannot establish the safety or harm of combination use.
Glucose lowering does not prove hypoglycemia
Neither inspected abstract provides an exact glipizide co-use analysis or a rate of clinically low glucose. The species name also cannot make concentrated extracts equivalent to the studied steamed plant or capsules.
Keep the diabetes team informed
Discuss the exact product and amount with the diabetes team before starting or changing it. Follow your established glucose-monitoring and low-glucose treatment plan; do not adjust glipizide yourself. Discuss major dietary changes as well as supplements; do not replace glipizide with nopal.
Evidence and practical considerations
Side effects & toxicity
Small preparation-specific glucose studies do not demonstrate added clinical hypoglycemia with glipizide; capsule trial withdrew oral medication.
- Exact scope
- Opuntia ficus-indica exact species; steamed nopal, dried capsules, fruit and extracts are different exposures. with Oral glipizide RxCUI4821 IN, immediate and extended release distinguished.
- Medication form and route
- oral medication; oral supplement
What remains uncertain
- Exact source preparation, medication and endpoint limits apply; no universal dose change or spacing.
Factors that may matter: Formulation; Dose and duration; Meal pattern; Other glucose-lowering agents; Kidney and liver function.
Read the supporting source summaries
Source 1: current product label
dailymed.nlm.nih.gov · Source check Sep 10, 2026
Population: Patients with type 2 diabetes receiving glipizide.
Glipizide can cause severe hypoglycemia; added glucose-lowering agents warrant observation. Nicotinic acid can worsen glycemic control; withdrawal also needs observation.
How this applies: Exact glipizide formulation and supplement preparation matter; other sulfonylureas and glucose efficacy endpoints are not automatically glipizide hypoglycemia evidence.
Separate formulations and meal instructions; no automatic transfer of immediate-release antacid pharmacokinetics to XL. Does not establish a risk rate for these herbs.
Source 2: current product label
dailymed.nlm.nih.gov · Source check Sep 10, 2026
Population: Patients with type 2 diabetes receiving glipizide.
Glipizide can cause severe hypoglycemia; added glucose-lowering agents warrant observation. Nicotinic acid can worsen glycemic control; withdrawal also needs observation.
How this applies: Exact glipizide formulation and supplement preparation matter; other sulfonylureas and glucose efficacy endpoints are not automatically glipizide hypoglycemia evidence.
Separate formulations and meal instructions; no automatic transfer of immediate-release antacid pharmacokinetics to XL. Does not establish a risk rate for these herbs.
Source 3: original human study
pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026
Population: 14type 2 diabetes participants; separate index study in7healthy people.
Steamed nopal lowered post-meal glucose response with a high-carbohydrate breakfast; meal composition affected responses.
How this applies: Exact glipizide formulation and supplement preparation matter; other sulfonylureas and glucose efficacy endpoints are not automatically glipizide hypoglycemia evidence.
14diabetic participants in meal experiment; no exact glipizide co-use or clinical hypoglycemia analysis in abstract. Food preparation does not represent every extract.
Source 4: original human study
pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026
Population: 10diabetic acute participants,10healthy OGTT participants,14diabetic crossover participants and5healthy participants.
Dried nopal capsules showed no acute glucose-lowering effect or OGTT effect; chronic comparison largely reflected glucose worsening during placebo.
How this applies: Exact glipizide formulation and supplement preparation matter; other sulfonylureas and glucose efficacy endpoints are not automatically glipizide hypoglycemia evidence.
Small studies; oral hypoglycemic treatment withdrawn in diabetic crossover arm, so not combination evidence.
Research assessment: · Open full citations ↗
Review and change history
- Publication status
- Published research summary
- Clinical review
- Not yet recorded
| Date | Update |
|---|---|
| Article prepared | |
| Prepared exact glipizide article preserving formulation, preparation and glucose endpoint distinctions. | |
| Research summary published |
Article revision: f26079a8c7f2545f
This guide brings together the evidence records used by our interaction checker. Each finding retains its own preparation limits, research date, and source summaries.
Full citations require verification. Reading this answer and the source summaries does not.
Taking other supplements or medications?
Use the checker to explore your other combinations. Ask a pharmacist to review the exact products, amounts and medical conditions in your complete list.
Open the interaction checkerInformation, not medical advice. Do not change prescribed treatment based on this guide.